The AF-HEART mHealth intervention demonstrated feasibility for remote tracking, weight loss, symptom reduction, and quality-of-life improvement in patients with atrial fibrillation (P=.03).
Cohort (n=20)
Does the AF-HEART mHealth intervention improve risk factor tracking, symptoms, and quality of life in patients with atrial fibrillation?
A pilot mHealth and telehealth intervention (AF-HEART) is feasible for remote tracking and may help achieve weight loss, symptom reduction, and quality-of-life improvement in patients with atrial fibrillation.
p-value: p=.03
Background: Personalized treatment of atrial fibrillation (AF) risk factors using mHealth and telehealth may improve patient outcomes. Objective: The purpose of this study was to assess the feasibility of the Atrial Fibrillation Helping Address Care with Remote Technology (AF-HEART) intervention on the following patient outcomes: (1) heart rhythm tracking; (2) weight, alcohol, blood pressure (BP), and sleep apnea reduction; (3) AF symptom reduction; and (4) quality-of-life (QOL) improvement. Methods: A total of 20 patients with AF undergoing antiarrhythmic therapy, cardioversion, and/or catheter ablation were enrolled and followed for 6 months. The AF-HEART intervention included remote heart rhythm, weight, and BP tracking; televisits with a dietician focusing on AF risk factors; and referrals for sleep apnea and hypertension treatment. Results: = .03). Conclusion: This study described the feasibility of the AF-HEART intervention for (1) consistent remote tracking of heart rhythm, weight, and BP; (2) achievement of weight loss; (3) reduction of symptoms; and (4) improvement in QOL. Expansion to a larger randomized study is planned.
Mitrani et al. (Tue,) conducted a cohort in Atrial fibrillation (n=20). AF-HEART intervention (mHealth and telehealth) was evaluated on Feasibility of heart rhythm tracking, risk factor reduction, symptom reduction, and quality-of-life improvement (p=.03). The AF-HEART mHealth intervention demonstrated feasibility for remote tracking, weight loss, symptom reduction, and quality-of-life improvement in patients with atrial fibrillation (P=.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: